DP2
Showing 1 - 25 of 4,377
Healthy Volunteers Trial in Hialeah (Amlitelimab DP1, Amlitelimab DP2)
Active, not recruiting
- Healthy Volunteers
- Amlitelimab DP1
- Amlitelimab DP2
-
Hialeah, FloridaClinical Pharmacology of Miami-Site Number: 8400001
Mar 29, 2023
HER2-positive Advanced Breast Cancer Trial (DP303c, Trastuzumab, Vinorelbine Tartrate)
Not yet recruiting
- HER2-positive Advanced Breast Cancer
- DP303c
- +3 more
- (no location specified)
Jun 4, 2023
HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)
Recruiting
- HER2-positive Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 10, 2023
Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))
Active, not recruiting
- Advanced Solid Tumors
- DS-8201a (DP1)
- +2 more
-
San Diego, California
- +13 more
Oct 4, 2022
HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)
Recruiting
- HNSCC
- +5 more
- DP CD8 TIL
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 5, 2023
COVID-19 Trial in Jakarta (ABO1009-DP, ABO-CoV.617.2, Placebo)
Recruiting
- COVID-19
- ABO1009-DP
- +2 more
-
Jakarta, Indonesia
- +1 more
Jul 25, 2022
COVID-19 Trial (ABO1009-DP)
Not yet recruiting
- COVID-19
- ABO1009-DP
- (no location specified)
Jul 11, 2022
Soil Transmitted Helminths, Schistosomiasis Mansoni Trial (Artificial Intelligence Digital Pathology)
Not yet recruiting
- Soil Transmitted Helminths
- Schistosomiasis Mansoni
- Artificial Intelligence Digital Pathology
- (no location specified)
Sep 29, 2023
Stroke Trial in Wishaw (Technology enriched stroke rehabilitation)
Not yet recruiting
- Stroke
- Technology enriched stroke rehabilitation
-
Wishaw, Lanarkshire, United KingdomUniversity Hospital Wishaw
Jul 31, 2023
Malaria,Falciparum, Anemia in Children Trial in Blantyre (Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine
Completed
- Malaria,Falciparum
- Anemia in Children
- Dihydroartemisinin-Piperaquine
- +2 more
-
Blantyre, MalawiKamuzu University of Health Sciences
Aug 4, 2023
Chikungunya Virus Infection Trial in San Juan (V184, Placebo)
Completed
- Chikungunya Virus Infection
- V184
- Placebo
-
San Juan, Puerto RicoSan Juan Hospital, Research Unit
Sep 6, 2022
Gastric Cancer Trial (DP303c treatment, DP303c treatment(second-line of HER2-positive), DP303c treatment (third-line of
Not yet recruiting
- Gastric Cancer
- DP303c treatment
- +4 more
- (no location specified)
Mar 30, 2021
MDD Trial in Israel, United States (Relivion®DP- Active, Relivion®DP- Sham)
Recruiting
- MDD
- Relivion®DP- Active
- Relivion®DP- Sham
-
La Jolla, California
- +13 more
Jan 12, 2023
COVID-19 Trial in Plymouth (MRx-4DP0004, Placebo)
Withdrawn
- COVID-19
- MRx-4DP0004
- Placebo
-
Plymouth, United KingdomUniversity Hospitals Plymouth NHS Trust
Jun 11, 2021
Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL) Trial in Canada, United States (botulinum toxin neuromodulator, Placebo)
Completed
- Glabellar Frown Lines (GL)
- Lateral Canthal Lines (LCL)
- botulinum toxin neuromodulator
- Placebo
-
Encino, California
- +11 more
Aug 24, 2022
Ovarian Cancer Trial in Chongqing (DP303c injection)
Not yet recruiting
- Ovarian Cancer
- DP303c injection
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 30, 2021
Diabetic Neuropathy Trial in H_olon (BOL-DP-o-04, Placebo)
Terminated
- Diabetic Neuropathy
- BOL-DP-o-04
- Placebo
-
H̱olon, IsraelWolfson Medical Center
Mar 22, 2021
Apical Periodontitis, Postoperative Pain, Cytokine Levels Trial in Samsun (Distilled water irrigation kept at 2.5°C degree,
Completed
- Apical Periodontitis
- +2 more
- Distilled water irrigation kept at 2.5°C degree
- Distilled water irrigation kept at room temperature
-
Samsun, TurkeyOndokuz Mayıs University Dp. Endodontics, Faculty of Dentistry
Jun 9, 2022
Non-syndromic Retinitis Pigmentosa Trial in Pittsburgh, Paris, London (Gene therapy: GS030-DP AND Medical device: GS030-MD)
Recruiting
- Non-syndromic Retinitis Pigmentosa
- Gene therapy: GS030-DP AND Medical device: GS030-MD
-
Pittsburgh, Pennsylvania
- +2 more
Jul 25, 2022
Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)
Recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Patients With nAMD in UK Routine Clinical Practice
Recruiting
- Neovascular Age-related Macular Degeneration
- brolucizumab
-
Peterborough, Cambridgeshire, United Kingdom
- +12 more
Jul 18, 2022
Airway Inflammation, Asthma Trial in United Kingdom (SYMBICORT and salbutamol)
Active, not recruiting
- Airway Inflammation
- Asthma
- SYMBICORT and salbutamol
-
Bradford, United Kingdom
- +5 more
Aug 22, 2022
Women Undergoing Assisted Reproductive Technology Treatment
Recruiting
- Adenomyosis
- +4 more
- Ultrasound diagnosis of adenomyosis
-
Birmingham, England, United Kingdom
- +5 more
Oct 3, 2022